KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2016 - 2025)

Ionis Pharmaceuticals has reported Interest Coverage Ratio over the past 17 years, most recently at 44.42 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 44.42 for Q4 2025, down 67.99% from a year ago — trailing twelve months through Dec 2025 was 22.11 (up 20.91% YoY), and the annual figure for FY2025 was 22.11, up 20.91%.
  • Interest Coverage Ratio for Q4 2025 was 44.42 at Ionis Pharmaceuticals, down from 38.03 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for IONS hit a ceiling of 98.57 in Q4 2021 and a floor of 120.17 in Q4 2022.
  • Median Interest Coverage Ratio over the past 5 years was 35.74 (2024), compared with a mean of 28.26.
  • Biggest five-year swings in Interest Coverage Ratio: surged 1158.61% in 2021 and later crashed 1868.73% in 2024.
  • Ionis Pharmaceuticals' Interest Coverage Ratio stood at 98.57 in 2021, then tumbled by 221.91% to 120.17 in 2022, then surged by 98.88% to 1.34 in 2023, then crashed by 1868.73% to 26.44 in 2024, then crashed by 67.99% to 44.42 in 2025.
  • The last three reported values for Interest Coverage Ratio were 44.42 (Q4 2025), 38.03 (Q3 2025), and 33.99 (Q2 2025) per Business Quant data.